Varubi
NDC 70720-101, rolapitant, tablet, from TerSera Therapeutics LLC.
- Product NDC
- 70720-101
- Status
- Listed
- Labeler
- TerSera Therapeutics LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA206500
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70720-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ROLAPITANT HYDROCHLORIDE90 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Neurokinin 1 Antagonists [MoA]; P-Glycoprotein Inhibitors [MoA]; Substance P/Neurokinin-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70720-101-02 | 70720010102 | 2 TABLET in 1 BLISTER PACK (70720-101-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a52896cd-4a98-49b8-82db-bf1985a64d97
Use it
Look up 70720-101 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70720-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70720-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.